Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Achilles Therapeutics PLC ADR

Current price
0.86 USD +0.0073 USD (+0.86%)
Last closed 0.84 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 36 853 808 USD
Yield for 12 month -16.11 %
21.11.2021 - 28.11.2021

Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom. Address: 245 Hammersmith Road, London, United Kingdom, W6 8PW

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

2.83 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-4 731 267 USD

Last Year

-3 687 722 USD

Current Quarter

-1 157 986 USD

Last Quarter

Key Figures ACHL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -66 116 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -25.08 %
PEG Ratio
Return On Equity TTM -40.84 %
Wall Street Target Price 2.83 USD
Revenue TTM
Book Value 3.17 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.6 USD
Diluted Eps TTM -1.6 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ACHL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ACHL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ACHL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 1.6583
Price Book MRQ 0.275

Financials ACHL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ACHL

For 52 weeks

0.74 USD 1.76 USD
50 Day MA 0.88 USD
Shares Short Prior Month 23 458
200 Day MA 0.93 USD
Short Ratio 0.19
Shares Short 11 059
Short Percent 0.04 %

Dynamics of changes in the value of assets



0.30 HKD Milestone Builder Holdings Ltd 0 (0%)
Detailed analytics


0.84 EUR CONCORD MED.ADR/3DL-0001 0 (0%)
Detailed analytics


0.0020 EUR YUANDA CHINA 0 (0%)
Detailed analytics


1 773.00 JPY Nippon Chutetsukan KK -0.18 (-1.55%)
Detailed analytics


0.057 EUR Chengdu PUTIAN Telecommunications Cable Company Limited 0 (0%)
Detailed analytics